Swixx Biopharma

About Swixx Biopharma

Swixx BioPharma is a pharmaceutical company that operates as a substitute for biopharma, over-the-counter (OTC) and medical device multinationals in countries or therapeutic areas that these multinationals choose not to enter or exit. Essentially, Swixx BioPharma fills the gap in markets that are overlooked by larger pharmaceutical companies, particularly in Central and Eastern Europe (CEE) and beyond.

Despite not having its own portfolio or conducting its own research and development (R&D), Swixx BioPharma upholds the standards and culture of a multinational pharmaceutical company. It leverages the expertise of its team, which is composed of seasoned professionals in the pharmaceutical industry, to provide access to modern medicines from its partners.

Swixx BioPharma's business model revolves around partnering with biopharma companies that prefer an indirect route to market. By offering top-tier pharma services and utilizing its deep industry knowledge, Swixx BioPharma aims to improve patient outcomes and create a healthier future for all.

The company works closely with its partners and the broader healthcare community to provide innovative treatments for patients in need. It aims to make a significant and lasting impact on the health of individuals and communities in the countries where it operates.

In terms of financials, Swixx BioPharma reported sales of over 700 million euros in 2022. The company was founded by a group of experienced pharma professionals with a deep understanding of biopharma’s needs.